|
BLOC1S2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.785000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.986600E-01 |
| Normal-vs-Stage2 |
8.917400E-01 |
| Normal-vs-Stage3 |
9.459400E-01 |
| Normal-vs-Stage4 |
5.239400E-01 |
| Stage1-vs-Stage2 |
8.170600E-01 |
| Stage1-vs-Stage3 |
6.747000E-01 |
| Stage1-vs-Stage4 |
8.702600E-01 |
| Stage2-vs-Stage3 |
9.421800E-01 |
| Stage2-vs-Stage4 |
7.633800E-01 |
| Stage3-vs-Stage4 |
6.424400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.954600E-01 |
| Normal-vs-AfricanAmerican |
7.067400E-01 |
| Normal-vs-Asian |
8.883800E-01 |
| Caucasian-vs-AfricanAmerican |
9.794200E-01 |
| Caucasian-vs-Asian |
9.681800E-01 |
| AfricanAmerican-vs-Asian |
9.535600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.796000E-01 |
| Normal-vs-Female |
6.814200E-01 |
| Male-vs-Female |
9.010800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.964800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.034800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.023200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.693200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.079200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.783800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.769800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.503200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.676000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.254600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.605600E-01 |
| Normal-vs-Grade 2 |
3.964800E-01 |
| Normal-vs-Grade 3 |
9.402200E-01 |
| Normal-vs-Grade 4 |
4.706200E-01 |
| Grade 1-vs-Grade 2 |
4.392800E-01 |
| Grade 1-vs-Grade 3 |
8.222400E-01 |
| Grade 1-vs-Grade 4 |
5.577200E-01 |
| Grade 2-vs-Grade 3 |
3.054800E-01 |
| Grade 2-vs-Grade 4 |
9.995400E-01 |
| Grade 3-vs-Grade 4 |
3.738200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.708800E-01 |
| Normal-vs-ccB subtype |
4.387400E-01 |
| ccA subtype-vs-ccB subtype |
4.334000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.091200E-01 |
| Normal-vs-N1 |
6.982600E-01 |
| N0-vs-N1 |
9.048600E-01 |
|
|
